A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...

MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight ...

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...